Back to results
US 9,845,325 B2Granted
Tetracyclic pyridone compounds as antivirals
AssigneeNovartis AG
InventorsJiping Fu, Xianming Jin, Patrick Lee, Peichao Lu, Joseph Michael Young
Life of this patent
Estimating the term…
Abstract
The invention provides compounds of Formula (I) as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by hepatitis B virus, and reducing the occurrence of serious conditions associated with HBV.
Claims15
A compound of formula (I):
- wherein:
- R1 is halo or C1-C3 alkyl;
- R2 is H, halo, CN, C1-C3 alkyl, C1-C3 haloalkyl, or C1-C3 alkoxy;
- R3 is OH, halo, CN, C1-C3 alkyl, C3-C6 cycloalkyl, C1-C3 haloalkyl, C1-C3 alkoxy, or C1-C3 haloalkoxy;
- R4 is selected from R11, —OR11, —SR11, and —NRR11;
- R11 is C1-C4 alkyl, C3-C6 cycloalkyl, oxetanyl, tetrahydrofuranyl, or tetrahydropyranyl, each of which is optionally substituted with up to three groups selected from halo, CN, —OR, C1-C3 haloalkoxy, —NR2, and a 4-7 membered heterocyclic group containing one or two heteroatoms selected from N, O and S as ring members that is optionally substituted with one or two groups selected from halo, oxo, CN, R, —OR, and —NR2;
- R is independently selected at each occurrence from H and C1-C3 alkyl optionally substituted with one to three groups selected from halo, —OH, C1-C3 alkoxy, oxo, CN, —NH2, —NH(C1-C3 alkyl), —N(C1-C3 alkyl)2, and cyclopropyl;
- and two R groups directly attached to the same atom, which may be C or N, can optionally be taken together to form a 3-6 membered ring that can optionally contain an added heteroatom selected from N, O and S as a ring member, and can be substituted by up to two groups selected from —OH, oxo, C1-C3 alkyl, and C1-C3 alkoxy;
- R5 is H, halo, CN, C1-C3 alkyl, or C1-C3 haloalkyl;
- R6 is H, halo, C1-C3 alkoxy, or C1-C6 alkyl;
- R7 is H, halo, C1-C3 alkoxy, or C1-C6 alkyl;
- R8 is H or C1-C6 alkyl;
- R9 taken together with one group selected from R6, R7 and R8 forms a 3-7 membered cycloalkyl ring or a 3-7 membered heterocyclic ring containing N, O or S as a ring member;
- wherein the cycloalkyl or heterocyclic ring is optionally substituted with up to three groups selected from R, —OR, —NR2, halo, CN, COOR, CONR2, and oxo;
- W is —COOR10, —C(O)NH—SO2R, —C(O)NH—SO2NR2, 5-tetrazolyl, or 1,2,4-oxadiazol-3-yl-5(4H)-one;
- R10 is H or C1-C6 alkyl that is optionally substituted with one or two groups selected from halo, —OR, oxo, CN, —NR2, COOR, and CONR2;
- or a pharmaceutically acceptable salt thereof.
14 more elements
Dependencies are inferred from the claim text.